APO A1-75 G to A substitution associated with severe forms of CAD, lower levels of HDL and apoA-I among Northern Indians

Disease Markers

Volumn 21, Issue 4, 2005, Pages 169-174

  Chhabra, S ^a   Narang, R ^a   Lakshmy, R ^a   Das, N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

APOA1; Apolipoprotein; CAD; India; Polymorphism

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; APOA1 PROTEIN, HUMAN;

ADULT; ALLELE; ANGIOGRAPHY; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIGESTION; DISEASE CARRIER; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; PATIENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TURBIDIMETRY; AGE; BIOSYNTHESIS; BLOOD; GENETICS; HOSPITALIZATION; INDIA; MIDDLE AGED; POINT MUTATION; SEX DIFFERENCE;

AGE FACTORS; ALLELES; APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; POINT MUTATION; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 30444455784     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/195078     Document Type: Article

References (30)

1. A.S. Wierzbicki, Have we forgotten the pivotal role of high density lipoprotein cholesterol in atherosclerosis prevention, Curr. Med. Res. Opin. 21 (2005), 299-306.
2. C.J. Fielding, V.G. Shore and P.E. Fielding, A protein co-factor of lecithin: cholesterol acyl transferase, Biochem. Biophys. Res. Commun. 46 (1972), 1493-1498.
3. S.K. Karathanasis, Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes, Proc. Natl. Acad. Sci. USA 82 (1985), 6374-6378.
4. G. Assmann, A. von Eckardstein and H. Funke, High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations, Circulation 87(Suppl III) (1993), III28-III34.
5. M. Groenendijk, R.M. Cantor, T.W.A. de Bruin and G.M. Dallinga-Thie, The ApoAI-CIII-AIV gene cluster, Atherosclerosis 157 (2001), 1-11.
6. F. Pagani, A. Sidoli, G.A. Giudici, L. Barenghi, C. Vergani and F.E. Baralle, Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia, J. Lipid Res. 31 (1990), 1371-1377.
7. Q.H. Meng, P. Pajukanta, L. Valsta, A. Aro, P. Pietinen and M.J. Tikkanen, Influence of apolipoprotein A-1 promoter polymorphism on lipid levels and responses to dietary change in Finnish adults, J. Intern. Med. 241 (1997), 373-378.
8. H. Paul-Hayase, M. Rosseneu, J.P. Van Bervliet, J.P. Deslypere and S.E. Humphries, Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations, Hum. Genet. 88 (1992), 439-446.
9. C.-F. Xu, F. Angelico, M. Del Ben and S. Humphries, Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apoAI levels in boys and girls, Genet. Epidemiol. 10 (1993), 113-122.
10. N. Saha, J.S.H. Tay, P.S. Low and S.E. Humphries, Guanidine to adenine (G > A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers, Genet. Epiciemiol. 11 (1994), 255-264.
11. P.J. Talmud, S. Ye and S.E. Humphries, Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study, Genet. Epidemiol. 11 (1994), 265-280.
12. G. Sigurdsson, Jr., V. Gudnason, G. Sigurdsson and S.E. Humphries, Interaction between a polymorphism of the Apo A-I promoter region and smoking determines plasma levels of HDL and Apo A-I, Arterioscler. Thromb. 12 (1992), 1017-1022.
13. A. Minnich, G. DeLangavant, J. Lavigne, G. Roederer, S. Lussier-Cacan and J. Davignon, G → A substitution at position - 75 of the Apolipoprotein A-I gene promoter-evidence against a direct effect on HDL cholesterol levels, Arterioscler. Thromb. Vasc. Biol. 15 (1995), 1740-1745.
14. M.I. Kamboh, C.E. Aston, C.M. Nestlerode, A.E. McAllister and R.F. Hamman, Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of apo A-I and HDL-cholesterol, Atherosclerosis 127 (1996), 255-262.
15. F. Civeira, M. Pocovi, A. Cenarro, C. Garces and J.M. Ordovas, Adenine for guanine substitution -78 base pairs to the apolipoprotein (APO) A-I gene: relation with high-density lipoprotein cholesterol and apoA-I concentrations, Clin. Genet. 44 (1993), 307-312.
16. D.E. Barre, R. Guerra, R. Verstraete, Z. Wang, S.M. Grundy and J.C. Cohen, Genetic analysis of a polymorphism in the human Apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levels, J. Lipid Res. 35 (1994), 1292-1296.
17. H. Akita, H. Chiba, M. Tsuji, S.P. Hui, Y. Takahashi, K. Malsuno and K. Kobayashi, Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency, Hum. Genet. 96 (1995), 521-526.
18. E.W.A. Needham, R.K. Mattu, A. Rees, I. Stocks and D.J. Galton, A polymorphism in the human apolipoprotein AI promoter region: a study in hypertriglyceridaemic patients, Hum. Hered. 44 (1994), 94-99.
19. R.E. Peacock, A. Hamsten, J. Johansson, P. Nilsson-Ehle and S.E. Humphries, Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high-density lipoprotein subclasses, Clin. Genet. 46 (1994), 273-282.
20. X.L. Wang, S.X. Liu, R.M. McCredie and D.E.L. Wilcken, Polymorphisms at the 5′-end of the apolipoprotein AI gene and severity of coronary artery disease, J. Clin. Invest. 98 (1996), 372-377.
21. K. Shoji, T. Mannani, Y. Kokubo, Y. Goto, H. Nonogi and N. Iwai, An association analysis between APOA1 polymorphisms and high density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese, J. Hum. Genet. 49 (2004), 433-439.
22. A. Matsunaga, J. Sasaki and T. Mori, Apolipoprotein A-I gene promoter polymorphism in patients with coronary artery disease and healthy controls, Nutr. Metab. Cardiovasc. Dis. 5 (1995), 269-275.
23. S.H.H. Juo, D.F. Wyszynski, T.H. Beaty, H.Y. Huang and J.E. Bailey-Wilson, Mild association between the A/G polymorphism in the promoter of the apolipoprotein A-I gene and apolipoprotein A-I levels: a metaanalysis, Am. J. Med. Genet. 82 (1999), 235-241.
24. J.R. Reguero, G.I. Cubero, A. Batalla, V. Alvarez, S. Hevia, A. Cortina and E. Coto, Apolipoprotein A1 gene polymorphisms and risk of early coronary disease, Cardiology 90 (1998), 231-235.
25. D. Petrovic, M. Tiore and B. Peterlin, Effect of apolipoprotein E polymorphism and apolipoprotein A-I gene promoter polymorphism lipid parameters and premature coronary artery disease, Folia Biol (Praha) 46(5) (2000), 181-185.
26. J.H. Wu, J.-T. Kao, M.-S. Wen and S.-K. Lo, DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index, J. Formos. Med. Assoc. 99 (2000), 367-374.
27. J.N. Mount, E.M. Kearney, M. Rosseneu and B.M. Slavin, Immunoturbidimetric assays for serum apolipoprotein A1 and B using Cobas biocentrifugal analyzer, J. Clin. Pathol. 41 (1988), 471-474.
28. S.A. Miller, D.D. Dykes and H.F. Polesky, A salting out procedure for extracting DNA from human nucleated cells, Nucleic acid Res 16 (1988), 1215.
29. V.K. Bahl, M. Vaswani, D. Thatai and H.S. Wasir, Plasma levels of apolipoprotein A-1 and B in Indian patients with angiographically defined coronary artery disease, Int. J. Cardiol. 46 (1994), 143-149.
30. R. Gupta, S. Vasisht, V.K. Bahl and H.S. Wasir, Correlation of lipoprotein(a) to angiographically defined coronary artery disease in Indians, Int. J. Cardiol. 57 (1996), 265-270.